Kathleen A Stringer

Title: Innovations in Sepsis Treatment by Kathleen A. Stringer

Introduction

Kathleen A. Stringer is a notable inventor based in Ann Arbor, MI (US), recognized for her contributions to the field of medical technology. With a focus on sepsis treatment, she has developed innovative methods that aim to improve patient outcomes. Her work has led to the issuance of 2 patents, showcasing her commitment to advancing healthcare solutions.

Latest Patents

One of her latest patents is titled "Serum metabolites as biomarkers for carnitine treatment of sepsis." This technology relates to treating septic shock and focuses on identifying sepsis patients who are most likely to benefit from L-carnitine treatment. Another significant patent is "Markers for sepsis treatment," which involves methods for predicting a sepsis patient's response to treatment with L-carnitine. These patents highlight her dedication to enhancing the understanding and treatment of sepsis.

Career Highlights

Kathleen has worked with prestigious institutions such as the University of Michigan and the University of Mississippi. Her experience in these organizations has allowed her to collaborate with leading experts in the field, further enriching her research and innovations.

Collaborations

Some of her notable coworkers include Alan E. Jones and Mike Puskarich. Their collaborative efforts have contributed to the development of effective treatment strategies for sepsis.

Conclusion

Kathleen A. Stringer's work in sepsis treatment exemplifies the impact of innovation in healthcare. Her patents and collaborations reflect her commitment to improving patient care through scientific advancements.